journal of men's health
Volume 6, Issue 1 , Pages 56-62 , March 2009

Prevalence of erectile dysfunction and its treatment in a Mexican population: distinguishing between erectile function change and dysfunction

  • Emily Wentzell, MA

      Affiliations

    • University of Michigan, Department of Anthropology and Unidad de Investigación Epidemiológica y en Servicios de Salud, Instituto Méxicano del Seguro Social, Mexico
    • Corresponding Author InformationCorresponding author.
    • ,
  • Jorge Salmerón, MD, DSc

      Affiliations

    • Unidad de Investigación Epidemiológica y en Servicios de Salud, Instituto Méxicano del Seguro Social, Mexico

Received 29 July 2008 ,Accepted 5 September 2008.

References 

  1. Potts A, Grace V, Gavey N, Vares T. “Viagra stories:” challenging ‘erectile dysfunction’. Soc Sci Med. 2004;59:489–499
  2. Tiefer L. In pursuit of the perfect penis: the medicalization of male sexuality. In: Sex is Not a Natural Act and Other Essays. Boulder: Westview Press; 1995;p. 141–156
  3. Loe M. The Rise of Viagra: How the Little Blue Pill Changed Sex in America. New York: New York University Press; 2004;
  4. Tiefer L. The medicalization of impotence: normalizing phallocentrism. Gend Soc. 1994;8(3):363–377
  5. Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol. 2005;35(1):93–99
  6. Seidella JC. Obesity, insulin resistance and diabetes – a worldwide epidemic. Br J Nutr. 2000;83:S5–S8
  7. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596–601
  8. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol. 2005;161(1):5–11
  9. Rivera JA, Barquera S, Campiranoa F, Camposa I, Safdiea M, Tovara V. Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity. Public Health Nutr. 2002;5:113–122
  10. CONAPO. Proyecciones de Población 2000–2050. Mexico City: Consejo Nacional de Poblacion; 2002.
  11. Barquera S, Durazo-Arvizu RA, Luke A, Cao G, Cooper RS. Hypertension in Mexico and among Mexican Americans: prevalence and treatment patterns. J Hum Hypertens. 2008;22(9):652
  12. Velázquez-Monroy O, Rosas P, Lara E, Pastelín H. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México. Arch Cardiol Mex. 2003;73(1):62–77
  13. Rulla JA, Aguilar-Salinasa CA, Rojasb R, Rios-Torresa JM, Gómez-Péreza FJ, Olaizb G. Epidemiology of type 2 diabetes in Mexico. Arch Med Res. 2005;36(3):188–196
  14. Ugarte y Romano F, Barroso-Aguirre J. Prevalencia de disfunción eréctil en México y factores de riesgo asociados. Rev Mex Urologia. 2001;61:63–76
  15. Hernández Moreno PN, Mendoza Martínez R, Hernández Marín I, Tovar Rodríguez J, Ayala A. Epidemiologic assessment of erectile function in a selected mexican population. Ginecol Obstet Mex. 2003;71:332–342
  16. Barroso-Aguirre J, Ugarte y Romano F. Pimentel-Nieto D. Prevalencia de disfunción eréctil en hombres de 18 a 40 años en México y factores de riesgo asociados. Perinatol Reprod Hum. 2001;15:254–261
  17. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. Men's attitudes to life events and sexuality (MALES) study. Curr Med Res Opin. 2004;20(5):607–617
  18. Glina S, Bertero E, Claro J, Damiao R, Faria G, Fregonesi A, et al. Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction in Brazilian and Mexican men. Int J Impot Res. 2002;14(Suppl 2):S27–S32
  19. Fisher WA, Rosen RC, Eardley I, Niederberger C, Nadel A, Kaufman J, et al. The multinational men's attitudes to life events and sexuality (MALES) study. Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. J Sex Med. 2004;1(2):150–160

PII: S1875-6867(08)00199-1

doi: 10.1016/j.jomh.2008.09.009

journal of men's health
Volume 6, Issue 1 , Pages 56-62 , March 2009

Article Tools

* Image Usage & Resolution